JPMorgan has unveiled its top stock picks for June, following a strong May that saw major U.S. indexes hit record highs, largely driven by technology stocks. The list includes pharmaceutical powerhouse Eli Lilly, bolstered by its weight-loss drug success and renewed focus on infectious diseases, and Viasat, a satellite broadband provider recently added to the recommendations. These selections reflect JPMorgan’s analysts’ strategic picks across growth, income, value, and short investment approaches.
READ MORE FROM CNBC
New York, NY – As June begins, Wall Street giant JPMorgan has updated its curated list of favored stocks, offering insights into the investment bank's top ideas from its analysts. The market closed May on a high note, with technology stocks spearheading a rally that saw all three major U.S. indexes reach record highs. The Nasdaq Composite climbed over 8%, the S&P 500 surged 5%, and the Dow Jones Industrial Average advanced 3%.
Each month, JPMorgan's analysts meticulously select top stock recommendations across various investment strategies, including growth, income, value, and short opportunities. These selections are specifically tailored to these strategies and may diverge from the bank's broader fundamental ratings.
This month's additions include Viasat, a global provider of high-speed satellite broadband services. The list highlights several key companies:
- Eli Lilly: The pharmaceutical giant has made significant strides in May, re-emphasizing its focus on vaccines and infectious disease treatments. Additionally, CVS Health's decision to reinstate coverage for Eli Lilly's blockbuster weight-loss injection, Zepbound, in its drug plans, further solidifies Lilly's market position against competitors like Novo Nordisk. Despite a market capitalization exceeding $1 trillion and numerous recent acquisitions, Wall Street analysts remain optimistic about Lilly. The company recently reached an all-time high, trading significantly above its 52-week low from the previous August.
- Viasat: This marks a new inclusion in JPMorgan's monthly recommendations. Viasat, a competitor to SpaceX's Starlink, has experienced substantial growth over the past year. Although its shares saw a recent dip after a stock and debt offering filing, Needham reiterated a buy rating and increased its price target. Viasat derives a significant portion of its revenue from communication services, with the remainder from defense and advanced technologies. The company recently secured a contract with Lockheed-Martin to support NOAA aircraft with its satellite communications platform.
JPMorgan's selections offer a glimpse into potential investment opportunities as the market navigates June, building on the positive momentum from May.